DK0923378T3 - Fremme af sårheling ved kemisk modificerede tetracykliner - Google Patents

Fremme af sårheling ved kemisk modificerede tetracykliner

Info

Publication number
DK0923378T3
DK0923378T3 DK97935248T DK97935248T DK0923378T3 DK 0923378 T3 DK0923378 T3 DK 0923378T3 DK 97935248 T DK97935248 T DK 97935248T DK 97935248 T DK97935248 T DK 97935248T DK 0923378 T3 DK0923378 T3 DK 0923378T3
Authority
DK
Denmark
Prior art keywords
activity
wound healing
capacity
epithelialized tissue
healing
Prior art date
Application number
DK97935248T
Other languages
Danish (da)
English (en)
Inventor
Lorne M Golub
Thomas F Mcnamara
Nungavaram S Ramamurthy
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of DK0923378T3 publication Critical patent/DK0923378T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97935248T 1996-08-01 1997-08-01 Fremme af sårheling ved kemisk modificerede tetracykliner DK0923378T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/691,135 US5827840A (en) 1996-08-01 1996-08-01 Promotion of wound healing by chemically-modified tetracyclines

Publications (1)

Publication Number Publication Date
DK0923378T3 true DK0923378T3 (da) 2006-04-03

Family

ID=24775298

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97935248T DK0923378T3 (da) 1996-08-01 1997-08-01 Fremme af sårheling ved kemisk modificerede tetracykliner

Country Status (11)

Country Link
US (1) US5827840A (de)
EP (1) EP0923378B1 (de)
JP (1) JP2000516214A (de)
KR (1) KR100494206B1 (de)
AT (1) ATE309804T1 (de)
AU (1) AU3823497A (de)
CA (1) CA2261805C (de)
DE (1) DE69734661T2 (de)
DK (1) DK0923378T3 (de)
ES (1) ES2255107T3 (de)
WO (1) WO1998005340A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
IL146132A0 (en) 1999-05-27 2002-07-25 Euro Celtique Sa Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments
EP1829546A1 (de) * 1999-09-14 2007-09-05 Mucosal Therapeutics LLC Formulierungen zur Behandlung oder Vorbeugung von Mucositis
AU779450B2 (en) * 1999-09-14 2005-01-27 Orapharma, Inc. Formulations for treating or preventing mucositis
US6946118B1 (en) * 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
NZ522733A (en) * 2000-06-02 2004-05-28 Yu Liu Non-antibacterial tetracycline as anti-fungal agents
NZ528197A (en) * 2001-04-05 2007-04-27 Collagenex Pharm Inc Use of a tetracycline compound of treating acne
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
NZ529308A (en) * 2001-04-05 2005-03-24 Collagenex Pharm Inc Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
EP2332546A1 (de) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclinverbindungen zur Behandlung von Schlaganfall
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
WO2003094954A1 (en) * 2001-09-25 2003-11-20 Quick Med Technologies, Inc. Composition and method for minimizing or avoiding adverse effects of vesicants
WO2003053447A1 (en) * 2001-12-20 2003-07-03 Hanauske-Abel Hartmut M Treatment for averting or delaying premature delivery
EP2311796A1 (de) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-Dedimethylamin-Tetracyclinverbindungen
AU2003220123B2 (en) 2002-03-08 2009-05-07 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
WO2003079984A2 (en) 2002-03-21 2003-10-02 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
AU2003230935B2 (en) * 2002-04-16 2008-08-07 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2003092629A2 (en) * 2002-05-06 2003-11-13 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating mucositis and fungal infection
WO2004006850A2 (en) 2002-07-12 2004-01-22 Paratek Pharmaceuticals, Inc 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
AU2003256496A1 (en) * 2002-07-12 2004-02-02 The Research Foundation Of State University Of New York Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
US20080139512A1 (en) * 2002-09-25 2008-06-12 Quick-Med Technologies, Inc. Method for minimizing or avoiding adverse effects of vesicants
DK1615622T3 (da) 2003-04-07 2012-10-15 Supernus Pharmaceuticals Inc Doxycyclinpræparater til indgivelse én gang dagligt
CN101786991A (zh) 2003-07-09 2010-07-28 帕拉特克药品公司 取代的四环素化合物
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
CA2544599A1 (en) * 2003-11-06 2005-05-26 Maria Emanuel Ryan Methods of treating eczema
JP5010284B2 (ja) 2004-01-15 2012-08-29 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の芳香族ａ環誘導体
EP2284150A3 (de) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen
AU2005299294B2 (en) 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
US20060252731A1 (en) * 2005-05-06 2006-11-09 Pfeiffer David F Methods of treating recurrent aphthous stomatitis
WO2007014154A2 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
ES2463457T3 (es) 2006-12-21 2014-05-28 Paratek Pharmaceuticals, Inc. Derivados de la tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias
PT2120963T (pt) * 2006-12-21 2018-12-17 Paratek Pharm Innc Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
CA2688662A1 (en) 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
ES2386926T3 (es) * 2007-07-06 2012-09-06 Paratek Pharmaceuticals, Inc. Métodos para sintetizar minociclina9-sustituida
TW202332671A (zh) * 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
RS54485B1 (en) 2008-08-08 2016-06-30 Tetraphase Pharmaceuticals, Inc. C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
US9315451B2 (en) 2009-05-08 2016-04-19 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
DK2470500T3 (en) 2009-08-28 2018-01-08 Tetraphase Pharmaceuticals Inc tetracycline
PL2552890T3 (pl) 2010-03-31 2017-07-31 Tetraphase Pharmaceuticals, Inc. Policykliczne związki tetracyklinowe
CA2883238C (en) 2012-08-31 2021-11-23 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CN104307031B (zh) * 2014-11-10 2015-12-30 刘维峰 一种皮肤外用修复材料的制备方法及用途
CN110582486B (zh) 2016-10-19 2024-01-12 四相制药公司 艾若威四环素的结晶形式
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767900U (de) * 1958-03-27 1958-06-04 Herbert Dipl Ing Fritzsche Hand- oder taschenleuchte mit blinker.
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US4016877A (en) * 1976-02-23 1977-04-12 Avicon, Inc. Fibrous collagen derived web having hemostatic and wound sealing properties
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4130555A (en) * 1977-09-06 1978-12-19 Nippi Incorporated Peptide mixtures derived from collagenous material or gelatin
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4440680A (en) * 1980-09-24 1984-04-03 Seton Company Macromolecular biologically active collagen articles
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4935412A (en) * 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4837024A (en) * 1984-02-24 1989-06-06 The Regents Of The University Of California Compositions, articles and mehtod for improving wound healing
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
US5196196A (en) * 1986-06-03 1993-03-23 Incyte Pharmaceuticals, Inc. Use of protease nexin-I in wound dressings
US4813942A (en) * 1987-03-17 1989-03-21 Bioderm, Inc. Three step wound treatment method and dressing therefor
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
US5227168A (en) * 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
JP3016587B2 (ja) * 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
GB9000846D0 (en) * 1990-01-15 1990-03-14 Beecham Group Plc Novel compounds
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
US5081106A (en) * 1990-07-16 1992-01-14 The Oregon Health Sciences University Wound dressing protocol utilizing collagen gelatin formed with iodine
US5156601A (en) * 1991-03-20 1992-10-20 Hydromer, Inc. Tacky, hydrophilic gel dressings and products therefrom
US5229380A (en) * 1991-06-28 1993-07-20 Harris Richard Y Method for treating helicobacter pylori gastritis
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
CA2103189C (en) * 1992-11-17 2005-05-03 Lorne M. Golub Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes

Also Published As

Publication number Publication date
DE69734661T2 (de) 2006-08-10
DE69734661D1 (de) 2005-12-22
ATE309804T1 (de) 2005-12-15
EP0923378B1 (de) 2005-11-16
KR100494206B1 (ko) 2005-06-13
WO1998005340A1 (en) 1998-02-12
CA2261805C (en) 2008-11-04
JP2000516214A (ja) 2000-12-05
ES2255107T3 (es) 2006-06-16
KR20000029753A (ko) 2000-05-25
EP0923378A4 (de) 2000-11-15
US5827840A (en) 1998-10-27
AU3823497A (en) 1998-02-25
EP0923378A1 (de) 1999-06-23
CA2261805A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DK0923378T3 (da) Fremme af sårheling ved kemisk modificerede tetracykliner
DK0489032T3 (da) Hydroxaminsyre-baserede kollagenaseinhibitorer
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
ES2155135T3 (es) Aposito en forma de gel para heridas.
EA200000825A1 (ru) Композиция, включающая ингибитор il-1 и полимер, контролирующий высвобождение
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
DE69902234D1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
ATE474572T1 (de) Heilung von wunden
DE60221884D1 (de) Mediziniscer verband
ATE471985T1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
DE69820254D1 (de) Dermales hüllgewebe in der wundheilung
ATE335501T1 (de) Mittel zur behandlung von allergischen oder überempfindlichkeitszuständen
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
AU5986498A (en) Use of aminothiazoles for treating wounds and skin
MY143194A (en) Topical pharmaceutical compositions for healing wounds
ATE234110T1 (de) Komponente b als wundheilendes mittel
RU2000106839A (ru) Способ лечения фурункулов лица
Demidov et al. Helium-neon laser in prophylaxis of suppuration and treatment of operative purulent wounds in tuberculous patients.
ITPD920102A1 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico
DE69912778D1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden